Menu
Currency
GWAS Study

Identification of PLCL1 gene for hip bone size variation in females in a genome-wide association study.

Liu YZ, Wilson SG, Wang L et al.

18776929 PubMed ID
GWAS Study Type
2216 Participants
64 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

LY
Liu YZ
WS
Wilson SG
WL
Wang L
LX
Liu XG
GY
Guo YF
LJ
Li J
YH
Yan H
DP
Deloukas P
SN
Soranzo N
CU
Chinappen-Horsley U
CA
Cervino A
WF
Williams FM
XD
Xiong DH
ZY
Zhang YP
JT
Jin TB
LS
Levy S
PC
Papasian CJ
DB
Drees BM
HJ
Hamilton JJ
RR
Recker RR
ST
Spector TD
DH
Deng HW
Chapter II

Abstract

Summary of the research findings

Osteoporosis, the most prevalent metabolic bone disease among older people, increases risk for low trauma hip fractures (HF) that are associated with high morbidity and mortality. Hip bone size (BS) has been identified as one of the key measurable risk factors for HF. Although hip BS is highly genetically determined, genetic factors underlying the trait are still poorly defined. Here, we performed the first genome-wide association study (GWAS) of hip BS interrogating approximately 380,000 SNPs on the Affymetrix platform in 1,000 homogeneous unrelated Caucasian subjects, including 501 females and 499 males. We identified a gene, PLCL1 (phospholipase c-like 1), that had four SNPs associated with hip BS at, or approaching, a genome-wide significance level in our female subjects; the most significant SNP, rs7595412, achieved a p value of 3.72x10(-7). The gene's importance to hip BS was replicated using the Illumina genotyping platform in an independent UK cohort containing 1,216 Caucasian females. Two SNPs of the PLCL1 gene, rs892515 and rs9789480, surrounded by the four SNPs identified in our GWAS, achieved p values of 8.62x10(-3) and 2.44x10(-3), respectively, for association with hip BS. Imputation analyses on our GWAS and the UK samples further confirmed the replication signals; eight SNPs of the gene achieved combined imputed p values<10(-5) in the two samples. The PLCL1 gene's relevance to HF was also observed in a Chinese sample containing 403 females, including 266 with HF and 177 control subjects. A SNP of the PLCL1 gene, rs3771362 that is only approximately 0.6 kb apart from the most significant SNP detected in our GWAS (rs7595412), achieved a p value of 7.66x10(-3) (odds ratio = 0.26) for association with HF. Additional biological support for the role of PLCL1 in BS comes from previous demonstrations that the PLCL1 protein inhibits IP3 (inositol 1,4,5-trisphosphate)-mediated calcium signaling, an important pathway regulating mechanical sensing of bone cells. Our findings suggest that PLCL1 is a novel gene associated with variation in hip BS, and provide new insights into the pathogenesis of HF.

501 European ancestry female individuals, 499 European ancestry male individuals

Chapter III

Study Statistics

Key metrics and study information

2216
Total Participants
GWAS
Study Type
Yes
Replicated
1,216 European ancestry female individuals
Replication Participants
European
Ancestry
U.K., U.S.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.